agilon health, inc.
AGL
$86.39
$5.827.22%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -0.98% | -8.07% | 48.53% | -5.71% | 9.69% |
| Total Depreciation and Amortization | -50.82% | -46.54% | -55.12% | -20.20% | 2.33% |
| Total Amortization of Deferred Charges | 30.48% | 30.48% | -- | -- | -- |
| Total Other Non-Cash Items | 231.86% | 59.80% | -93.55% | -82.08% | -79.13% |
| Change in Net Operating Assets | -18.06% | -25.91% | -0.50% | 513.05% | 302.36% |
| Cash from Operations | 24.04% | -51.63% | 62.58% | 58.52% | 70.67% |
| Capital Expenditure | 33.25% | 24.03% | 25.52% | 3.95% | -25.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 53.33% | -47.75% | -35.65% | 89.00% | 65.09% |
| Cash from Investing | 71.83% | -50.00% | -37.69% | 108.45% | 12.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -40.00% | -- | 100.00% | 75.00% | 33.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 96.45% | 61.64% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2,536.02% | -- | -- | -- | -- |
| Cash from Financing | -134.45% | -6.78% | 18.88% | -606.61% | 98.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 262.05% | -125.67% | 171.21% | 164.92% | 107.02% |